Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus

BACKGROUND: Influenza virus remains a continuous and severe threat to public health worldwide, and its prevention and treatment have always been a major international issue. Because of its ability to evade immune surveillance through rapid antigenic drift and antigenic shift, broad-spectrum vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jingjin, Huang, Nan, Fan, Menglu, Zhao, Lingcai, Luo, Yan, Ding, Pingyun, Tian, Miao, Liu, Qingzheng, Guo, Yanna, Zhao, Jinhua, Zheng, Yiqing, Zhang, Haitao, Ping, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720065/
https://www.ncbi.nlm.nih.gov/pubmed/33287849
http://dx.doi.org/10.1186/s12985-020-01458-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720065/
https://www.ncbi.nlm.nih.gov/pubmed/33287849
http://dx.doi.org/10.1186/s12985-020-01458-z

Ejemplares similares